Cirrhosis Increasing Among Hepatitis C Patients, According to Large US Study

The past decade has seen a nearly 40 percent increase in the prevalence of cirrhosis among people with hepatitis C in the U.S., a new study found. The reasons remain uncertain, however. The study, titled “Hepatitis C Complications: Prevalence and Disparities in a Large US Cohort 2006-2014” (abstract #180) was presented at The Liver Meeting 2016, held by the American Association for the Study of Liver Diseases (AASLD). Cirrhosis has long been linked t

U.S.: Hillary Clinton calls out drug maker Gilead over price of hepatitis C pills

WASHINGTON, Aug. 18 (UPI) -- Democratic presidential nominee Hillary Clinton said Wednesday her administration will go after drug companies that charge exorbitant prices, singling out the company Gilead, whose hepatitis C drugs cost between $900 and $1,000 per pill in the United States. Gilead's hepatitis C drug cures what had been a chronic liver condition diagnosed in more than 3 million Americans that can lead to increased risk of cirrhosis and liver c

US: Judge allows public employees access to pricey hepatitis C drugs

Members of the Washington’s Public Employees Benefits Board infected with hepatitis C will be able to receive expensive drugs that can cure the life-threatening disease, a judge ruled Wednesday. A King County Superior Court judge has ordered the agency that oversees health insurance for Washington’s public employees to pay for expensive drugs to treat hepatitis C in all patients, not just those with the most severe illness. Judge Suzanne R. Parisien gr

Hepatitis C Deaths Rising in US

The number of deaths from hepatitis C in the U.S. is on the rise, and the increase is hitting particularly hard among middle-age people, a new study from the Centers for Disease Control and Prevention (CDC) reports.The study found that the number of deaths in the U.S. from hepatitis C rose from 11,051 in 2003 to 19,368 in 2013. And baby boomers, or those ages 55 to 64, accounted for 51 percent of the deaths in 2013, according to the study, published online

U.S.: Senator ‘appalled’ by hospitals’ objection to providing Hep C test

TRENTON — The chairman of the Senate health committee slammed lobbyists representing hospitals and doctors Monday for opposing a bill that would require them to screen their baby-boomer patients, those born between 1945 and 1965, for Hepatitis C, saying that their objections are "absurd" and they "ought to be ashamed of themselves."The state Senate Health, Human Services and Senior Citizens Committee approved the legislation, but not before Chairman Joseph